KD Logo

Protara Therapeutics Inc [NASDAQ: TARA] Sees Increase in Stock Value

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Protara Therapeutics Inc shares valued at $17,598 were sold by Opaleye Management Inc. on Jul 01 ’24. At $2.12 per share, Opaleye Management Inc. sold 8,288 shares. The insider’s holdings dropped to 87,500 shares worth approximately $0.18 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Opaleye Management Inc. sold 17,994 shares, netting a total of over 37,334 in proceeds. Following the sale of shares at $2.07 each, the insider now holds 85,000 shares.

Before that, Opaleye Management Inc. had sold 46,574 shares from its account. In a trade valued at $105,169, the 10% Owner traded Protara Therapeutics Inc shares for $2.26 each. Upon closing the transaction, the insider’s holdings decreased to 46,574 shares, worth approximately $0.19 million.

Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of February 17, 2021, Oppenheimer has initiated its “an Outperform” rating for TARA. Earlier on October 19, 2020, Cowen initiated its rating. Their recommendation was “an Outperform” for TARA stock.

Analyzing TARA Stock Performance

During the last five days, there has been a surge of approximately 5.88%. Over the course of the year, Protara Therapeutics Inc shares have jumped approximately 10.39%. Shares of the company reached a 52-week high of $5.24 on 04/05/24 and a 52-week low of $1.80 on 01/22/24. A 50-day SMA is recorded $2.75, while a 200-day SMA reached $2.49. Nevertheless, trading volume fell to 63257.0 shares from 68800.0 shares the previous day.

Support And Resistance Levels for Protara Therapeutics Inc (TARA)

According to the 24-hour chart, there is a support level at 2.01, which, if violated, would cause prices to drop to 1.92. In the upper region, resistance lies at 2.16. The next price resistance is at 2.22. RSI (Relative Strength Index) is 34.06 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.18, which suggests the price will decrease in the coming days. Percent R is at 73.39%, indicating bearish price movement. Stochastics%K at holding indicates that the stock is to be held.

Most Popular